Stronger Crackdown Needed on Clandestine Laboratories Manufacturing Dangerous Drugs
GGD-82-6: Published: Nov 6, 1981. Publicly Released: Nov 6, 1981.
Additional Materials:
- Full Report:
Contact:
(202) 512-7797
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
GAO assessed whether the Federal Government is mounting an effective attack on illicitly manufactured dangerous drugs and whether current legal sanctions pose a reasonable degree of risk to dangerous drug traffickers.
In spite of concerted efforts by a few Drug Enforcement Administration (DEA) field offices which have produced an impressive increase in the number of clandestine laboratory seizures, clandestine laboratories continue to flourish. The battle against illegal laboratory operations is falling behind because: (1) the Federal strategy of achieving the highest possible level of risk for drug trafficking through appropriate sentencing has not been achieved; (2) DEA devotes more resources to investigating traffickers in cocaine and, in some cases, cannabis, both lower priority drugs, than to investigating traffickers in dangerous drugs, even though dangerous drugs have the second highest enforcement priority, surpassed only by heroin; and (3) DEA is not fully using and developing the precursor liaison program which is the most important tool available for detecting and suppressing clandestine laboratories. Additional resources would help DEA deal with the dangerous drugs problem. But, given present economic conditions, a significant increase in resources is unlikely. Nevertheless, it is important that a more effective attack be mounted against clandestine laboratories because their product is deadly, and the laboratory drugs, unlike heroin, which is imported, have a domestic source. A strong domestic drug law enforcement program is essential in order for the United States to convince other nations of its commitment to control drug abuse and achieve international cooperation in drug control.
Matter for Congressional Consideration
Status: Closed - Implemented
Comments: When we determine what steps the Congress has taken, we will provide updated information.
Matter: Congress should amend the Controlled Substances Act to increase the maximum penalties for trafficking in all Schedules I and II nonnarcotic drugs, including phencyclidine, to equal the maximum penalties for trafficking in Schedules I and II narcotic drugs.
Recommendations for Executive Action
Status: Closed - Implemented
Comments: When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Recommendation: The Attorney General should direct the Administrator of the Drug Enforcement Administration (DEA) to analyze field offices' use of investigative resources that deviate from the high enforcement priority ranking assigned to dangerous drugs and, where deviations are not justified, formulate plans to allocate investigative resources commensurate with the severity of the problem.
Agency Affected: Department of Justice
Status: Closed - Implemented
Comments: When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Recommendation: The Attorney General should direct the Administrator of DEA to direct field offices to comply with the requirements of the precursor liaison program and to establish procedures to be followed by DEA headquarters staff in monitoring field offices' compliance with such requirements.
Agency Affected: Department of Justice
Status: Closed - Implemented
Comments: When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Recommendation: The Attorney General should direct the Administrator of DEA to carry out the current plans to implement the precursor chemical information system developed by the DEA Offices of Enforcement and Intelligence in 1979.
Agency Affected: Department of Justice
Explore the full database of GAO's Open Recommendations
»
Oct 26, 2020
-
Intellectual Property:
CBP Has Taken Steps to Combat Counterfeit Goods in Small Packages but Could Streamline EnforcementGAO-20-692: Published: Sep 24, 2020. Publicly Released: Oct 26, 2020.
Sep 30, 2020
-
Federal Criminal Restitution:
Department of Justice Has Ongoing Efforts to Improve Its Oversight of the Collection of Restitution and Tracking the Use of Forfeited AssetsGAO-20-676R: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 10, 2020
-
Federal Tactical Teams:
Characteristics, Training, Deployments, and InventoryGAO-20-710: Published: Sep 10, 2020. Publicly Released: Sep 10, 2020.
Sep 8, 2020
-
VA Police:
Actions Needed to Improve Data Completeness and Accuracy on Use of Force Incidents at Medical CentersGAO-20-599: Published: Sep 8, 2020. Publicly Released: Sep 8, 2020.
Aug 13, 2020
-
Anti-Money Laundering:
FinCEN Should Enhance Procedures for Implementing and Evaluating Geographic Targeting OrdersGAO-20-546: Published: Jul 14, 2020. Publicly Released: Aug 13, 2020.
Jul 29, 2020
-
Federal Prison Industries:
Actions Needed to Evaluate Program EffectivenessGAO-20-505: Published: Jul 29, 2020. Publicly Released: Jul 29, 2020.
Jul 8, 2020
-
Gun Control:
DOJ Can Further Improve Guidance on Federal Firearm Background Check RecordsGAO-20-528: Published: Jul 8, 2020. Publicly Released: Jul 8, 2020.
Jun 22, 2020
-
Federal Prisons:
Additional Analysis Needed to Determine Whether to Issue Pepper Spray to Minimum Security PrisonsGAO-20-342: Published: Jun 22, 2020. Publicly Released: Jun 22, 2020.
May 26, 2020
-
Bureau of Prisons:
Improved Planning Would Help BOP Evaluate and Manage Its Portfolio of Drug Education and Treatment ProgramsGAO-20-423: Published: May 26, 2020. Publicly Released: May 26, 2020.
May 12, 2020
-
Forensic Technology:
Algorithms Used in Federal Law EnforcementGAO-20-479SP: Published: May 12, 2020. Publicly Released: May 12, 2020.
Looking for more? Browse all our products here